Evidence map›Paper›PMID 38151225›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Kidney Function Measures and Mortality: A Mendelian Randomization Study.

Ying Shan, Jingwen Zhang, Yueqi Lu, Jinlan Liao, Yuyang Liu, Liang Dai, Jing Li, Congying Song, Guobin Su, Sara Hägg and 4 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Ying ShanClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Jingwen ZhangRenal Division, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Yueqi LuBGI-Shenzhen, Shenzhen, China.
Jinlan LiaoRenal Division, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Yuyang LiuBGI-Shenzhen, Shenzhen, China.
Liang DaiClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Jing LiRenal Division, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Congying SongClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Guobin SuDepartment of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Sara HäggClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Zuying XiongRenal Division, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Dorothea NitschDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Juan Jesus CarreroDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Xiaoyan HuangClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China; Renal Division, Peking University Shenzhen Hospital, Peking University, Shenzhen, China. Electronic address: huangxiaoyan@pku.org.cn.
Peking University Shenzhen Hospital · CNBGI Group (China) · CNKarolinska Institutet · SEGuangzhou University of Chinese Medicine · CNLondon School of Hygiene & Tropical Medicine · GB

Funding

Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
NIDDK NIH HHS R01 DK115534
6 · The paper itself

Abstract

RATIONALE &

objectiveIndividuals with a low estimated glomerular filtration rate (eGFR) are at a high risk of death. However, the causes underpinning this association are largely uncertain. This study aimed to assess the causal relationship of low eGFR with all-cause and cause-specific mortality. STUDY

designRetrospective cohort study incorporating Mendelian randomization (MR). SETTING &

participantsIndividual-level data from 436,214 White participants (54.3% female; aged 56.8±8.0 years) included in the UK Biobank. EXPOSURES: eGFR estimated using cystatin C (eGFR OUTCOMES: The outcomes of interest included all-cause mortality, cardiovascular mortality, cancer mortality, infection mortality, and other-cause mortality. ANALYTICAL APPROACH: Cox proportional hazards analysis for the conventional observational analyses; linear and nonlinear MR analyses implemented using genetic allele scores as instrumental variables representing kidney function to estimate the effect of kidney function on the survival outcomes.

resultsDuring a median follow-up of 12.1 years, there were 30,489 deaths, 6,098 of which were attributed to cardiovascular events, 15,538 to cancer, 1,516 to infection, and 7,227 to other events. In the conventional observational analysis, eGFR LIMITATIONS: Potential misclassification of the actual cause of death, a nonrepresentative sample, and potential error in the interpretation of the magnitude of associations generated in MR analyses.

conclusionsThese findings suggest a potential causal association between low eGFR and cardiovascular mortality in the general population, but no causal relationship with all-cause mortality or noncardiovascular mortality was observed. Further studies in other populations are warranted to confirm these findings. PLAIN-LANGUAGE SUMMARY: This study investigated the existence of a causal relationship between lower kidney function and death of different causes. Using data from 436,214 people in the United Kingdom, we applied conventional statistical analyses and those incorporating genetic data to implement Mendelian randomization, an approach that estimates causal associations. The observational analysis showed a nonlinear association between kidney function and various types of mortality outcomes. However, Mendelian randomization analysis suggested a linear increase in the risk of cardiovascular mortality with lower kidney function, but no causal link between the level of kidney function and all-cause or noncardiovascular mortality was identified. Managing kidney health may help reduce cardiovascular mortality, but caution is needed in interpreting the magnitudes of these results. Further validation in other populations and in those with advanced kidney failure is needed.

Indexed as

Cause of DeathGlomerular Filtration RateMendelian Randomization AnalysisAgedCardiovascular DiseasesCohort StudiesCystatin CFemaleHumansKidney Function TestsMaleMiddle AgedRetrospective StudiesUnited KingdomCystatin Ccardiovascular mortalityCystatin Cestimated glomerular filtration rateMendelian randomizationUK Biobank

Identifiers

PMID38151225
PMCPMC11116063
OpenAlexW4390198389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.